nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—JUN—hindbrain—autistic disorder	0.021	0.0926	CbGeAlD
Irbesartan—JUN—mouth—autistic disorder	0.0184	0.0812	CbGeAlD
Irbesartan—UGT1A3—digestive system—autistic disorder	0.0144	0.0635	CbGeAlD
Irbesartan—JUN—brainstem—autistic disorder	0.012	0.0531	CbGeAlD
Irbesartan—JUN—eye—autistic disorder	0.0117	0.0516	CbGeAlD
Irbesartan—JUN—forebrain—autistic disorder	0.0116	0.0512	CbGeAlD
Irbesartan—JUN—telencephalon—autistic disorder	0.0107	0.0471	CbGeAlD
Irbesartan—AGTR1—forebrain—autistic disorder	0.00873	0.0386	CbGeAlD
Irbesartan—JUN—digestive system—autistic disorder	0.00814	0.0359	CbGeAlD
Irbesartan—JUN—head—autistic disorder	0.00664	0.0293	CbGeAlD
Irbesartan—JUN—nervous system—autistic disorder	0.0063	0.0278	CbGeAlD
Irbesartan—JUN—central nervous system—autistic disorder	0.00606	0.0268	CbGeAlD
Irbesartan—JUN—cerebellum—autistic disorder	0.00592	0.0262	CbGeAlD
Irbesartan—CYP2D6—hindbrain—autistic disorder	0.0057	0.0252	CbGeAlD
Irbesartan—EDNRA—brain—autistic disorder	0.00527	0.0233	CbGeAlD
Irbesartan—AGTR1—head—autistic disorder	0.005	0.0221	CbGeAlD
Irbesartan—JUN—brain—autistic disorder	0.00481	0.0212	CbGeAlD
Irbesartan—AGTR1—nervous system—autistic disorder	0.00474	0.0209	CbGeAlD
Irbesartan—AGTR1—central nervous system—autistic disorder	0.00456	0.0202	CbGeAlD
Irbesartan—PTGS1—forebrain—autistic disorder	0.00384	0.017	CbGeAlD
Irbesartan—AGTR1—brain—autistic disorder	0.00362	0.016	CbGeAlD
Irbesartan—PTGS1—telencephalon—autistic disorder	0.00353	0.0156	CbGeAlD
Irbesartan—CYP2D6—brainstem—autistic disorder	0.00327	0.0144	CbGeAlD
Irbesartan—CYP2D6—forebrain—autistic disorder	0.00316	0.0139	CbGeAlD
Irbesartan—CYP1A2—digestive system—autistic disorder	0.00311	0.0137	CbGeAlD
Irbesartan—CYP2C9—digestive system—autistic disorder	0.00295	0.013	CbGeAlD
Irbesartan—CYP2D6—telencephalon—autistic disorder	0.0029	0.0128	CbGeAlD
Irbesartan—PTGS1—digestive system—autistic disorder	0.00269	0.0119	CbGeAlD
Irbesartan—CYP3A4—digestive system—autistic disorder	0.00225	0.00994	CbGeAlD
Irbesartan—CYP2D6—digestive system—autistic disorder	0.00221	0.00978	CbGeAlD
Irbesartan—PTGS1—head—autistic disorder	0.0022	0.00971	CbGeAlD
Irbesartan—PTGS1—nervous system—autistic disorder	0.00208	0.0092	CbGeAlD
Irbesartan—PTGS1—central nervous system—autistic disorder	0.00201	0.00886	CbGeAlD
Irbesartan—CYP2C8—brain—autistic disorder	0.00196	0.00867	CbGeAlD
Irbesartan—CYP2D6—head—autistic disorder	0.00181	0.00798	CbGeAlD
Irbesartan—CYP3A4—nervous system—autistic disorder	0.00174	0.00769	CbGeAlD
Irbesartan—CYP2D6—nervous system—autistic disorder	0.00171	0.00756	CbGeAlD
Irbesartan—CYP3A4—central nervous system—autistic disorder	0.00168	0.0074	CbGeAlD
Irbesartan—CYP2D6—central nervous system—autistic disorder	0.00165	0.00728	CbGeAlD
Irbesartan—CYP2D6—cerebellum—autistic disorder	0.00161	0.00712	CbGeAlD
Irbesartan—PTGS1—brain—autistic disorder	0.00159	0.00703	CbGeAlD
Irbesartan—CYP2D6—brain—autistic disorder	0.00131	0.00578	CbGeAlD
Irbesartan—CYP2C8—Metabolism—ADA—autistic disorder	8.4e-05	0.000109	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOE—autistic disorder	8.37e-05	0.000108	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	8.31e-05	0.000107	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—POMC—autistic disorder	8.27e-05	0.000107	CbGpPWpGaD
Irbesartan—JUN—Immune System—PRKCB—autistic disorder	8.23e-05	0.000106	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TDO2—autistic disorder	8.23e-05	0.000106	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—POMC—autistic disorder	8.21e-05	0.000106	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PRL—autistic disorder	8.19e-05	0.000106	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR2A—autistic disorder	8.13e-05	0.000105	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2—autistic disorder	8.12e-05	0.000105	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTM5—autistic disorder	8.08e-05	0.000105	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ASMT—autistic disorder	8.08e-05	0.000105	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IGF1—autistic disorder	7.96e-05	0.000103	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	7.96e-05	0.000103	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	7.95e-05	0.000103	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—MAPK1—autistic disorder	7.92e-05	0.000102	CbGpPWpGaD
Irbesartan—JUN—Immune System—EGF—autistic disorder	7.79e-05	0.000101	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ADSL—autistic disorder	7.78e-05	0.000101	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ADRB2—autistic disorder	7.77e-05	0.0001	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DHCR7—autistic disorder	7.74e-05	0.0001	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TSC2—autistic disorder	7.72e-05	9.98e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ADSL—autistic disorder	7.71e-05	9.97e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—RORA—autistic disorder	7.66e-05	9.91e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—XDH—autistic disorder	7.63e-05	9.86e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC25A12—autistic disorder	7.6e-05	9.83e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—XDH—autistic disorder	7.56e-05	9.78e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SERPINE1—autistic disorder	7.56e-05	9.77e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOE—autistic disorder	7.56e-05	9.77e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—LEP—autistic disorder	7.56e-05	9.77e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PIK3CG—autistic disorder	7.55e-05	9.76e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—STX1A—autistic disorder	7.49e-05	9.68e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NPAS2—autistic disorder	7.49e-05	9.68e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—STX1A—autistic disorder	7.42e-05	9.6e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NPAS2—autistic disorder	7.42e-05	9.6e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC19A1—autistic disorder	7.39e-05	9.56e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC6A8—autistic disorder	7.34e-05	9.49e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—EXT1—autistic disorder	7.34e-05	9.49e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AVP—autistic disorder	7.3e-05	9.43e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—MAPK1—autistic disorder	7.28e-05	9.41e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IGF2—autistic disorder	7.26e-05	9.39e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	7.25e-05	9.37e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TCN2—autistic disorder	7.23e-05	9.35e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—POMC—autistic disorder	7.19e-05	9.29e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MAOB—autistic disorder	7.18e-05	9.28e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TCN2—autistic disorder	7.17e-05	9.27e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PRKCB—autistic disorder	7.12e-05	9.21e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DAO—autistic disorder	7e-05	9.05e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ADA—autistic disorder	6.9e-05	8.92e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PLA2G4A—autistic disorder	6.86e-05	8.87e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ADA—autistic disorder	6.84e-05	8.84e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—autistic disorder	6.83e-05	8.84e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PIK3CG—autistic disorder	6.82e-05	8.81e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APC—autistic disorder	6.82e-05	8.81e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	6.79e-05	8.78e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	6.76e-05	8.74e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EGF—autistic disorder	6.74e-05	8.71e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP19A1—autistic disorder	6.74e-05	8.71e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—UPB1—autistic disorder	6.71e-05	8.68e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TPH2—autistic disorder	6.68e-05	8.63e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MEF2C—autistic disorder	6.67e-05	8.63e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ADSL—autistic disorder	6.59e-05	8.52e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—DPYD—autistic disorder	6.57e-05	8.49e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ITGB3—autistic disorder	6.5e-05	8.41e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—POMC—autistic disorder	6.49e-05	8.39e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	6.47e-05	8.37e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—XDH—autistic disorder	6.46e-05	8.36e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—HRAS—autistic disorder	6.36e-05	8.22e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—STX1A—autistic disorder	6.34e-05	8.2e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NPAS2—autistic disorder	6.34e-05	8.2e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	6.32e-05	8.17e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—BCL2—autistic disorder	6.3e-05	8.14e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—RORA—autistic disorder	6.29e-05	8.13e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—COMT—autistic disorder	6.26e-05	8.1e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IGF1—autistic disorder	6.24e-05	8.07e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNG—autistic disorder	6.24e-05	8.07e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ASMT—autistic disorder	6.24e-05	8.07e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTM5—autistic disorder	6.24e-05	8.07e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—RORA—autistic disorder	6.24e-05	8.06e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTP1—autistic disorder	6.23e-05	8.06e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MAOA—autistic disorder	6.22e-05	8.04e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—MAPK1—autistic disorder	6.21e-05	8.03e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	6.17e-05	7.97e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TCN2—autistic disorder	6.13e-05	7.92e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2—autistic disorder	6.11e-05	7.91e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CACNA1C—autistic disorder	6.11e-05	7.89e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—autistic disorder	6.08e-05	7.87e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR2A—autistic disorder	6.07e-05	7.85e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CAT—autistic disorder	6.06e-05	7.84e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SERPINE1—autistic disorder	5.93e-05	7.66e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MAOB—autistic disorder	5.9e-05	7.62e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—autistic disorder	5.87e-05	7.59e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC25A12—autistic disorder	5.87e-05	7.58e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—HRAS—autistic disorder	5.85e-05	7.56e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ADA—autistic disorder	5.84e-05	7.56e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MAOB—autistic disorder	5.84e-05	7.56e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	5.78e-05	7.47e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TSC2—autistic disorder	5.77e-05	7.46e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PTEN—autistic disorder	5.75e-05	7.44e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGS2—autistic disorder	5.73e-05	7.41e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PLA2G4A—autistic disorder	5.73e-05	7.4e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTM1—autistic disorder	5.73e-05	7.4e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC19A1—autistic disorder	5.71e-05	7.38e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—LEP—autistic disorder	5.64e-05	7.3e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOE—autistic disorder	5.64e-05	7.3e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—autistic disorder	5.6e-05	7.23e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	5.56e-05	7.19e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—DHFR—autistic disorder	5.56e-05	7.18e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2—autistic disorder	5.54e-05	7.17e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	5.53e-05	7.15e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GPX1—autistic disorder	5.48e-05	7.09e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TPH2—autistic disorder	5.48e-05	7.09e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TPH2—autistic disorder	5.43e-05	7.02e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—DPYD—autistic disorder	5.39e-05	6.97e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—DPYD—autistic disorder	5.35e-05	6.91e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—RORA—autistic disorder	5.33e-05	6.89e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PRKCB—autistic disorder	5.32e-05	6.88e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—PTEN—autistic disorder	5.22e-05	6.74e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APC—autistic disorder	5.09e-05	6.59e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PIK3CG—autistic disorder	5.09e-05	6.59e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ADSL—autistic disorder	5.09e-05	6.58e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MTHFR—autistic disorder	5.06e-05	6.54e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EGF—autistic disorder	5.04e-05	6.51e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	5.02e-05	6.49e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CACNA1C—autistic disorder	5.01e-05	6.48e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTEN—autistic disorder	5e-05	6.46e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MAOB—autistic disorder	4.99e-05	6.46e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HRAS—autistic disorder	4.99e-05	6.45e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—XDH—autistic disorder	4.99e-05	6.45e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CACNA1C—autistic disorder	4.97e-05	6.42e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—STX1A—autistic disorder	4.9e-05	6.33e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NPAS2—autistic disorder	4.9e-05	6.33e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—POMC—autistic disorder	4.85e-05	6.27e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2—autistic disorder	4.8e-05	6.2e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	4.78e-05	6.18e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—autistic disorder	4.77e-05	6.17e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	4.75e-05	6.15e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TCN2—autistic disorder	4.73e-05	6.11e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOE—autistic disorder	4.71e-05	6.09e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	4.68e-05	6.05e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MAPK1—autistic disorder	4.68e-05	6.05e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IGF1—autistic disorder	4.66e-05	6.03e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TPH2—autistic disorder	4.64e-05	6e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DPYD—autistic disorder	4.57e-05	5.91e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—DHFR—autistic disorder	4.56e-05	5.9e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—DHFR—autistic disorder	4.52e-05	5.85e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PTEN—autistic disorder	4.51e-05	5.84e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ADA—autistic disorder	4.51e-05	5.83e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SERPINE1—autistic disorder	4.43e-05	5.73e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP19A1—autistic disorder	4.35e-05	5.62e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	4.29e-05	5.55e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PIK3CG—autistic disorder	4.25e-05	5.5e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CACNA1C—autistic disorder	4.25e-05	5.49e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—MAPK1—autistic disorder	4.24e-05	5.48e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—RORA—autistic disorder	4.11e-05	5.32e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	4.08e-05	5.28e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	4.08e-05	5.28e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—POMC—autistic disorder	4.05e-05	5.23e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—COMT—autistic disorder	4.04e-05	5.23e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTP1—autistic disorder	4.03e-05	5.2e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MAOA—autistic disorder	4.02e-05	5.19e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CAT—autistic disorder	3.92e-05	5.06e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DHFR—autistic disorder	3.86e-05	4.99e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MAOB—autistic disorder	3.85e-05	4.98e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	3.81e-05	4.93e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HRAS—autistic disorder	3.76e-05	4.85e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PLA2G4A—autistic disorder	3.7e-05	4.78e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTM1—autistic disorder	3.7e-05	4.78e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MAPK1—autistic disorder	3.67e-05	4.75e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—autistic disorder	3.59e-05	4.65e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2—autistic disorder	3.58e-05	4.63e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TPH2—autistic disorder	3.58e-05	4.63e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP19A1—autistic disorder	3.57e-05	4.62e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GPX1—autistic disorder	3.54e-05	4.58e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP19A1—autistic disorder	3.54e-05	4.58e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DPYD—autistic disorder	3.53e-05	4.56e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—HRAS—autistic disorder	3.41e-05	4.4e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PTEN—autistic disorder	3.37e-05	4.36e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	3.32e-05	4.3e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—COMT—autistic disorder	3.32e-05	4.29e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTP1—autistic disorder	3.31e-05	4.27e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MAOA—autistic disorder	3.3e-05	4.26e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—COMT—autistic disorder	3.29e-05	4.26e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CACNA1C—autistic disorder	3.28e-05	4.24e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTP1—autistic disorder	3.28e-05	4.24e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MTHFR—autistic disorder	3.27e-05	4.23e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MAOA—autistic disorder	3.27e-05	4.23e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—autistic disorder	3.26e-05	4.21e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	3.26e-05	4.21e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—autistic disorder	3.23e-05	4.17e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CAT—autistic disorder	3.22e-05	4.16e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CAT—autistic disorder	3.19e-05	4.12e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOE—autistic disorder	3.04e-05	3.94e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PLA2G4A—autistic disorder	3.04e-05	3.93e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTM1—autistic disorder	3.04e-05	3.93e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP19A1—autistic disorder	3.03e-05	3.91e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PLA2G4A—autistic disorder	3.01e-05	3.89e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTM1—autistic disorder	3.01e-05	3.89e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DHFR—autistic disorder	2.98e-05	3.85e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HRAS—autistic disorder	2.95e-05	3.81e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GPX1—autistic disorder	2.91e-05	3.76e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GPX1—autistic disorder	2.88e-05	3.73e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.84e-05	3.67e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—autistic disorder	2.82e-05	3.65e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTEN—autistic disorder	2.82e-05	3.64e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—COMT—autistic disorder	2.81e-05	3.64e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTP1—autistic disorder	2.8e-05	3.62e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MAOA—autistic disorder	2.79e-05	3.61e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PIK3CG—autistic disorder	2.75e-05	3.55e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MAPK1—autistic disorder	2.74e-05	3.55e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CAT—autistic disorder	2.72e-05	3.52e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MTHFR—autistic disorder	2.68e-05	3.47e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MTHFR—autistic disorder	2.66e-05	3.44e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—POMC—autistic disorder	2.61e-05	3.38e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PLA2G4A—autistic disorder	2.57e-05	3.33e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTM1—autistic disorder	2.57e-05	3.33e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOE—autistic disorder	2.5e-05	3.23e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOE—autistic disorder	2.48e-05	3.2e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GPX1—autistic disorder	2.46e-05	3.19e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP19A1—autistic disorder	2.34e-05	3.02e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MTHFR—autistic disorder	2.27e-05	2.94e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PIK3CG—autistic disorder	2.26e-05	2.92e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PIK3CG—autistic disorder	2.24e-05	2.89e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HRAS—autistic disorder	2.2e-05	2.85e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—COMT—autistic disorder	2.17e-05	2.81e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTP1—autistic disorder	2.16e-05	2.79e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MAOA—autistic disorder	2.16e-05	2.79e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—POMC—autistic disorder	2.15e-05	2.78e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—POMC—autistic disorder	2.13e-05	2.75e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOE—autistic disorder	2.12e-05	2.74e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—autistic disorder	2.11e-05	2.72e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CAT—autistic disorder	2.1e-05	2.72e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—autistic disorder	2.09e-05	2.7e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLA2G4A—autistic disorder	1.99e-05	2.57e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTM1—autistic disorder	1.99e-05	2.57e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PIK3CG—autistic disorder	1.91e-05	2.47e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GPX1—autistic disorder	1.9e-05	2.46e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTEN—autistic disorder	1.82e-05	2.35e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—POMC—autistic disorder	1.82e-05	2.35e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MTHFR—autistic disorder	1.75e-05	2.27e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—autistic disorder	1.71e-05	2.21e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—autistic disorder	1.7e-05	2.19e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOE—autistic disorder	1.63e-05	2.11e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTEN—autistic disorder	1.49e-05	1.93e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTEN—autistic disorder	1.48e-05	1.91e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PIK3CG—autistic disorder	1.47e-05	1.91e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—autistic disorder	1.45e-05	1.88e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—POMC—autistic disorder	1.4e-05	1.81e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTEN—autistic disorder	1.27e-05	1.64e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—autistic disorder	1.12e-05	1.45e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTEN—autistic disorder	9.76e-06	1.26e-05	CbGpPWpGaD
